Zobrazeno 1 - 10
of 271
pro vyhledávání: '"Olav Dahl"'
Autor:
Olav Dahl, Mette Pernille Myklebust
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: MicroRNA (MiR) influences the growth of cancer by regulation of mRNA for 50–60% of all genes. We present as per our knowledge the first global analysis of microRNA expression in anal cancer patients and their prognostic impact. Methods
Externí odkaz:
https://doaj.org/article/c3b2eb1cdf764e089cee52fce6978ecc
Autor:
Ingrid G Rekeland, Kari Sørland, Lisbeth Lykke Neteland, Alexander Fosså, Kine Alme, Kristin Risa, Olav Dahl, Karl J Tronstad, Olav Mella, Øystein Fluge
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0307484 (2024)
ObjectivesIn this six-year follow-up study, we used patient-reported outcome measures (PROMs) to compare values at baseline, at 18 months, and at six-year follow up from the CycloME and the RituxME trials.MethodsBased on the hypothesis that ME/CFS in
Externí odkaz:
https://doaj.org/article/9db27675e3104d3783d621dcffdfcd06
Autor:
Mette Pernille Myklebust, Anna Thor, Benedikte Rosenlund, Peder Gjengstø, Ása Karlsdottir, Marianne Brydøy, Bogdan S. Bercea, Christian Olsen, Ida Johnson, Mathilde I. Berg, Carl W. Langberg, Kristine E. Andreassen, Anders Kjellman, Hege S. Haugnes, Olav Dahl
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract MicroRNA-371a-3p (miR371) has been suggested as a sensitive biomarker in testicular germ cell cancer (TGCC). We aimed to compare miR371 with the classical biomarkers α-fetoprotein (AFP) and β-human chorionic gonadotropin (hCGβ). Overall,
Externí odkaz:
https://doaj.org/article/007a32cb6b57433c9a8d6a521c3627cb
Autor:
Kjersti Elvestad Hestetun, Nina Benedikte Rosenlund, Luka Stanisavljević, Olav Dahl, Mette Pernille Myklebust
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionDeficient mismatch repair (dMMR) or high microsatellite instability (MSI-H) is associated with an improved prognosis in colon cancer stage II but poor prognosis in stage IV colon cancer. The clinical significance of dMMR in colon cancer s
Externí odkaz:
https://doaj.org/article/9cd6bd6de8d5484f8dfce4fe150d5ed4
Autor:
Christian Ekanger, MD, Svein Inge Helle, MD, PhD, Daniel Heinrich, MD, Dag Clement Johannessen, MD, Ása Karlsdóttir, MD, PhD, Yngve Nygård, MD, PhD, Ole Johan Halvorsen, MD, PhD, Lars Reisæter, MD, Rune Kvåle, MD, PhD, Liv Bolstad Hysing, M.Sc., PhD, Olav Dahl, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 3, Pp 396-403 (2020)
Purpose: There is no consensus on how to treat high-risk prostate cancer, and long-term results from hypofractionated radiation therapy are lacking. We report 10-year results after image guided, intensity modulated radiation therapy with hypofraction
Externí odkaz:
https://doaj.org/article/003bcf4b4bdd4a4ea72acb895b16503a
Autor:
Ingrid G. Rekeland, Kari Sørland, Ove Bruland, Kristin Risa, Kine Alme, Olav Dahl, Karl J. Tronstad, Olav Mella, Øystein Fluge
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Introduction Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease with no validated specific and sensitive biomarker, and no standard approved treatment. In this observational study with no intervention, participants used a Fitbit
Externí odkaz:
https://doaj.org/article/c47dd4bbb3624934a3e60b3b30244074
Autor:
Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad
Publikováno v:
JCI Insight, Vol 6, Iss 16 (2021)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly
Externí odkaz:
https://doaj.org/article/901b1669aa974902b55a2279b6b28774
Autor:
Lars Fredrik Fjæra, MSc, Daniel J. Indelicato, MD, Kristian S. Ytre-Hauge, PhD, Ludvig P. Muren, PhD, Yasmin Lassen-Ramshad, MD, Laura Toussaint, PhD, Olav Dahl, MD, Camilla H. Stokkevåg, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100551- (2021)
Purpose: During radiation therapy for pediatric brain tumors, the brainstem is a critical organ at risk, possibly with different radio-sensitivity across its substructures. In proton therapy, treatment planning is currently performed using a constant
Externí odkaz:
https://doaj.org/article/4cab0ce5a4e5416382eb9bb140ead8f0
Autor:
Jon Espen Dale, Silvia Molinelli, Barbara Vischioni, Viviana Vitolo, Maria Bonora, Giuseppe Magro, Andrea Mairani, Azusa Hasegawa, Tatsuya Ohno, Olav Dahl, Francesca Valvo, Piero Fossati
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background and PurposeThe Italian National Center of Oncological Hadrontherapy (CNAO) has applied dose constraints for carbon ion RT (CIRT) as defined by Japan’s National Institute of Radiological Sciences (NIRS). However, these institutions use di
Externí odkaz:
https://doaj.org/article/4bc5f16d20e0407399700be2493a6248
Autor:
Ingrid G. Rekeland, Alexander Fosså, Asgeir Lande, Irini Ktoridou-Valen, Kari Sørland, Mari Holsen, Karl J. Tronstad, Kristin Risa, Kine Alme, Marte K. Viken, Benedicte A. Lie, Olav Dahl, Olav Mella, Øystein Fluge
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Introduction: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease with high symptom burden, of unknown etiology, with no established treatment. We observed patients with long-standing ME/CFS who got cancer, and who reported impro
Externí odkaz:
https://doaj.org/article/7b56f5bed2a34ef297d880101d98d971